Artificial intelligence (AI) has left almost no field untouched, and kidney care is no exception. From mundane tasks such as note-taking, to diagnostic and prognostic predictions, AI has many uses in clinical care and its impact is already being felt.
Len A. Usvyat, PhD, is senior vice president and head of the Renal Research Institute, which aims to improve the outcomes of patients with kidney disease through research and innovation. Dr. Usvyat joined Nephrology Times to talk about AI’s potential and how to address the risks of its utilization in health care.